Revisiting Neo-Ponden (Androisoxazol): The Obscure Oral Steroid

Examining Its Intended Effects and Minimal Bodybuilding History

Background and Development

Neo-Ponden contains the obscure steroid compound androisoxazol, which is a modified derivative of DHT. Androisoxazol was synthesized by scientists in the 1950s-1960s during research into altering testosterone-based hormones.

Androisoxazol possesses a 17-alpha-methyl group to improve oral bioavailability. It also contains an isoxazole group instead of the 3-keto group on DHT. This aimed to reduce androgenic side effects while enhancing anabolic activity.

However, androisoxazol failed to gain much popularity or adoption over other oral steroids. Neo-Ponden was produced only briefly before disappearing from pharmaceutical development. Supply remained extremely limited even on black markets.

Intended Effects

Although data is lacking, the intentions behind Neo-Ponden were to create an oral steroid retaining the lean mass building effects of DHT but with lowered estrogenic side effects.

It was reputed to provide moderate but high quality muscle and strength gains without excess bulk or water retention, comparable to popular steroids like Winstrol and Anavar.

However, these purported effects were never substantiated through human trials. Any potential benefits or side effects remain speculative without verified evidence and testing.

Obscurity and Disappearance

Within just a few years of limited circulation, Neo-Ponden completely disappeared as other oral steroids proved far more effective for physique enhancement purposes.

Today Neo-Ponden remains extremely rare, essentially a novelty item with no human or veterinary uses. While an interesting experimental compound, it ultimately proved ineffective and short-lived.

In summary, Neo-Ponden represented another failed oral steroid unable to live up to its theoretical potential. Knowledge and options have only improved dramatically over the decades since.